Patents by Inventor Jonathan Boutell
Jonathan Boutell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20260071270Abstract: Some examples herein provide a sequencing flowcell that includes an imaging sensor, a hydrogel disposed on the imaging sensor and comprising a moiety; and a first complex non-covalently coupled to the moiety, the first complex comprising a first oligonucleotide. A method of using the sequencing flowcell may include decoupling the first complex from the moiety; and coupling a second complex to the moiety, the second complex comprising a second oligonucleotide. Methods of forming the flowcell are also provided.Type: ApplicationFiled: July 17, 2025Publication date: March 12, 2026Applicant: Illumina, Inc.Inventors: Claudia Battistella, Gabriele Canzi, Katharina Mueller-Ott, Wayne George, Jonathan Boutell
-
Publication number: 20250263790Abstract: A method of determining sequence information from two or more polynucleotide sequence portions, the method comprising: selecting one of a plurality of classifications based on first and second intensity data, wherein each classification represents one or more possible combinations of respective nucleobases of the two or more polynucleotide sequence portions, and wherein at least one classification represents more than one possible combination of respective nucleobases.Type: ApplicationFiled: March 15, 2023Publication date: August 21, 2025Inventors: Jonathan BOUTELL, Niall GORMLEY, Gery VESSERE, Aathavan KARUNAKARAN, Eli CARRAMI, Oliver MILLER, Stephen BRUINSMA, Shagesh SRIDHARAN, Nileshi SARAF
-
Publication number: 20250207193Abstract: The present subject matter relates to reusable flow cells, uses of reusable flow cells, methods of manufacturing a reusable flow cell and methods of regenerating a reusable flow cell.Type: ApplicationFiled: December 20, 2024Publication date: June 26, 2025Applicant: Illumina, Inc.Inventors: Jonathan Boutell, Jason Betley, Pietro Gatti Lafranconi, Xiaolin Wu, Oliver Miller
-
Publication number: 20250188529Abstract: In some examples, a device includes a flowcell including wells, and a plurality of molecules. Each molecule may include a single respective polynucleotide. At least some of the wells are coupled to a single respective one of the molecules such that a single respective polynucleotide is coupled to those wells. The device also may include a plurality of particles. Each particle may include amplification primers and may be coupled to a single one of the wells via hybridization between an amplification primer of that particle and the polynucleotide of the molecule coupled to that well.Type: ApplicationFiled: December 11, 2024Publication date: June 12, 2025Applicant: Illumina, Inc.Inventors: Xavier von Hatten, Gianluca Artioli, Nam Nguyen, Jonathan Boutell
-
Publication number: 20250115957Abstract: Some examples herein provide a sequencing flowcell that includes an imaging sensor; a hydrogel disposed on the imaging sensor and comprising a moiety; and a first complex non-covalently coupled to the moiety, the first complex comprising a first oligonucleotide. A method of using the sequencing flowcell may include decoupling the first complex from the moiety; and coupling a second complex to the moiety, the second complex comprising a second oligonucleotide. Methods of forming the flowcell are also provided.Type: ApplicationFiled: September 26, 2024Publication date: April 10, 2025Applicant: Illumina, Inc.Inventors: Claudia Battistella, Gabriele Canzi, Katharina Mueller-Ott, Wayne George, Jonathan Boutell
-
Publication number: 20250084402Abstract: The invention relates to methods and kits for use in nucleic acid sequencing, in particular methods for use in concurrent sequencing, including concurrent sequencing of tandem insert libraries. Further, the invention relates to methods of detecting mismatched base pairs in nucleic acid sequences. In another embodiment, the disclosed technology relates to using next generation sequencing to determine the nucleotide sequences of two or more polynucleotide sequence portions in a single sequencing run.Type: ApplicationFiled: September 13, 2024Publication date: March 13, 2025Inventors: Eli CARRAMI, Jonathan BOUTELL, Oliver MILLER, Aathavan KARUNAKARAN, Stephen BRUINSMA, Niall GORMLEY, Gery VESSERE, Roberto ANDRES, Michael BUREK, Shagesh SRIDHARAN, Nileshi SARAF, Come RACZY, Jeff GAU
-
Publication number: 20240425907Abstract: The present disclosure is generally directed to strategies for spatial multiomics via target nucleic acid capture and amplification.Type: ApplicationFiled: June 20, 2024Publication date: December 26, 2024Inventors: Niall Gormley, Anurag Agrawal, Mathieu Lessard-Viger, Jonathan Boutell, Eli Carrami
-
Publication number: 20240360503Abstract: The invention relates to methods for use in nucleic acid sequencing, in particular methods for use in concurrent sequencing.Type: ApplicationFiled: March 15, 2023Publication date: October 31, 2024Inventors: Gery VESSERE, Aathavan KARUNAKARAN, Come RACZY, Jeff GAU, Jonathan BOUTELL, Roberto ANDRES, Michael BUREK, Eli CARRAMI
-
Publication number: 20240352515Abstract: A method of base calling nucleobases of two or more polynucleotide sequence portions, wherein said polynucleotide sequence portions have been selectively processed such that an intensity of the signals obtained based upon the respective first nucleobase is greater than an intensity of the signals obtained based upon the respective second nucleobase.Type: ApplicationFiled: March 15, 2023Publication date: October 24, 2024Inventors: Gery VESSERE, Aathavan KARUNAKARAN, Come RACZY, Jeff GAU, Jonathan BOUTELL, Roberto ANDRES, Michael BUREK, Eli CARRAMI
-
Publication number: 20240309423Abstract: Automated methods conducted in a sequencing flowcell, and kits for reusing a flowcell, are provided herein. In some examples, an automated method conducted in a sequencing flowcell may include, at a surface of the sequencing flowcell coupled to a first moiety, using a reagent to decouple a first complex from the first moiety. In some examples, the first complex may include a second moiety which couples to the first moiety and a polynucleotide coupled to the second moiety. In some examples, the method may further include using a nuclease to polynucleotides in the sequencing flowcell. The method may include, after using the reagent and after using the nuclease, coupling a second complex to the first moiety. The second complex may include a third moiety which couples with the first moiety and an oligonucleotide coupled to the third moiety.Type: ApplicationFiled: March 5, 2024Publication date: September 19, 2024Applicant: Illumina, Inc.Inventors: Jonathan Boutell, Katharina Mueller-Ott, Jason Betley, Xiaolin Wu, Wayne George, Pietro Gatti Lafranconi, Andrew Brown
-
Publication number: 20240279733Abstract: The present disclosure is directed to decoupling library capture (template seeding) from cluster generation to optimise both processes. This is achieved by introducing orthogonality between the seeding and clustering primer.Type: ApplicationFiled: December 15, 2022Publication date: August 22, 2024Applicant: Illumina, Inc.Inventors: Fei Shen, Mathieu Lessard-Viger, Eric Brustad, Allison Meade, Esteban Armijo, Michael Howard, Jeffrey Fisher, Jonathan Boutell, Ramon Saracho, Olivia Ghazinejad, Seth McDonald, Lena Storms, Jeffrey Brodin
-
Publication number: 20240263229Abstract: The present disclosure is generally directed to strategies for template capture and amplification during sequencing.Type: ApplicationFiled: December 15, 2022Publication date: August 8, 2024Applicant: Illumina, Inc.Inventors: Xiaoyu Ma, Mathieu Lessard-Viger, Jeffrey Fisher, Jonathan Boutell
-
Publication number: 20240117424Abstract: Reusable flow cells for sequencing which exhibit signal intensity retention over numerous use cycles, the active surface of which contains poly-azide functional moieties, methods of treating flow cells surfaces with reagents to provide such poly-azide functional moieties, and reagents therefor.Type: ApplicationFiled: September 12, 2023Publication date: April 11, 2024Applicant: Illumina, Inc.Inventors: Jonathan Boutell, Wayne George, Xiaolin Wu
-
Publication number: 20240102067Abstract: This disclosure relates to novel mjresynthesis kits and methods, in particular for use in pairwise sequencing.Type: ApplicationFiled: September 25, 2023Publication date: March 28, 2024Applicant: Illumina, Inc.Inventors: Kay Klausing, Jonathan Boutell, Trina Osothprarop, Oliver Miller, Justin Robbins
-
Publication number: 20230348973Abstract: The present disclosure is generally directed to strategies for template capture and amplification during sequencing. In some examples, a solid support is used for template capture and amplification.Type: ApplicationFiled: March 30, 2023Publication date: November 2, 2023Applicant: ILLUMINA CAMBRIDGE LIMITEDInventors: Xiaoyu Ma, Mathieu Lessard-Viger, Eric Brustad, Jeffrey Fisher, Jonathan Boutell, Weihua Chang
-
Patent number: 11661627Abstract: An example method includes reacting a first solution and a different, second solution on a flow cell by flowing the first solution over amplification sites on the flow cell and subsequently flowing the second solution over the amplification sites. The first solution includes target nucleic acids and a first reagent mixture that comprises nucleoside triphosphates and replication enzymes. The target nucleic acids in the first solution transport to and bind to the amplification sites at a transport rate. The first reagent mixture amplifies the target nucleic acids that are bound to the amplification sites to produce clonal populations of amplicons originating from corresponding target nucleic acids. The amplicons are produced at an amplification rate that exceeds the transport rate. The second solution includes a second reagent mixture and lacks the target nucleic acids. The second solution is to increase a number of the amplicons at the amplification sites.Type: GrantFiled: September 25, 2020Date of Patent: May 30, 2023Assignees: Illumina, Inc., Illumina Cambridge LimitedInventors: Shaun Hunter, Peter McInerney, Jonathan Boutell, Claire Bevis-Mott
-
Publication number: 20220333178Abstract: A method for seeding and amplifying target nucleic acids derived from a sample in a cluster at a site on a surface of a substrate includes retaining at least a portion of the target nucleic acids in an inactive form that cannot seed to provide a relatively low concentration of active form target nucleic acids available for seeding. As the active form target nucleic acids seed on the surface of the substrate, they may be amplified. Because the concentration of active form target nucleic acids is low, the likelihood is low that a second active form target nucleic acid will seed at the same site within the same cluster before the first active form target nucleic acid is sufficiently amplified to dominate. Accordingly, the likelihood that the cluster will pass filters is increased relative to traditional seeding and amplification methods employing a higher concentration of active form target nucleic acids.Type: ApplicationFiled: March 21, 2022Publication date: October 20, 2022Inventors: Gary Mark Skinner, Geraint Evans, Niall Gormley, Jonathan Boutell, Matthew W. Kellinger, Michael Previte, Molly He
-
Publication number: 20210010071Abstract: An example method includes reacting a first solution and a different, second solution on a flow cell by flowing the first solution over amplification sites on the flow cell and subsequently flowing the second solution over the amplification sites. The first solution includes target nucleic acids and a first reagent mixture that comprises nucleoside triphosphates and replication enzymes. The target nucleic acids in the first solution transport to and bind to the amplification sites at a transport rate. The first reagent mixture amplifies the target nucleic acids that are bound to the amplification sites to produce clonal populations of amplicons originating from corresponding target nucleic acids. The amplicons are produced at an amplification rate that exceeds the transport rate. The second solution includes a second reagent mixture and lacks the target nucleic acids. The second solution is to increase a number of the amplicons at the amplification sites.Type: ApplicationFiled: September 25, 2020Publication date: January 14, 2021Inventors: Shaun Hunter, Peter McInerney, Jonathan Boutell, Claire Bevis-Mott
-
Patent number: 10808277Abstract: An example method includes reacting a first solution and a different, second solution on a flow cell by flowing the first solution over amplification sites on the flow cell and subsequently flowing the second solution over the amplification sites. The first solution includes target nucleic acids and a first reagent mixture that comprises nucleoside triphosphates and replication enzymes. The target nucleic acids in the first solution transport to and bind to the amplification sites at a transport rate. The first reagent mixture amplifies the target nucleic acids that are bound to the amplification sites to produce clonal populations of amplicons originating from corresponding target nucleic acids. The amplicons are produced at an amplification rate that exceeds the transport rate. The second solution includes a second reagent mixture and lacks the target nucleic acids. The second solution is to increase a number of the amplicons at the amplification sites.Type: GrantFiled: December 15, 2017Date of Patent: October 20, 2020Assignees: ILLUMINA, INC., ILLUMINA CAMBRIDGE LIMITEDInventors: Shaun Hunter, Peter McInerney, Jonathan Boutell, Claire Bevis-Mott
-
Publication number: 20180187252Abstract: An example method includes reacting a first solution and a different, second solution on a flow cell by flowing the first solution over amplification sites on the flow cell and subsequently flowing the second solution over the amplification sites. The first solution includes target nucleic acids and a first reagent mixture that comprises nucleoside triphosphates and replication enzymes. The target nucleic acids in the first solution transport to and bind to the amplification sites at a transport rate. The first reagent mixture amplifies the target nucleic acids that are bound to the amplification sites to produce clonal populations of amplicons originating from corresponding target nucleic acids. The amplicons are produced at an amplification rate that exceeds the transport rate. The second solution includes a second reagent mixture and lacks the target nucleic acids. The second solution is to increase a number of the amplicons at the amplification sites.Type: ApplicationFiled: December 15, 2017Publication date: July 5, 2018Inventors: Shaun Hunter, Peter McInerney, Jonathan Boutell, Claire Bevis-Mott